Jörg Spiekerkötter
Chief Executive Officer chez JSP-Invest GmbH
Profil
Jörg Spiekerkötter is currently the Chairman & Managing Director at JSP-Invest GmbH and a Member-Supervisory Board at Dr. Loges + Co. GmbH.
Previously, he worked as the Chief Financial Officer at Bayer Schering Pharma AG from 1999 to 2006, Chief Financial Officer at Organon BioSciences NV from 2006 to 2007, Legal Head at Hoechst Schering AgrEvo GmbH from 1994 to 1999, Member-Supervisory Board at PAION AG from 2007 to 2010, and Chief Financial Officer & Head-Investor Relations at Conergy AG in 2010.
Postes actifs de Jörg Spiekerkötter
| Sociétés | Poste | Début |
|---|---|---|
JSP-Invest GmbH
 JSP-Invest GmbH Financial ConglomeratesFinance JSP-Invest GmbH is a private company based in Potsdam, Germany. The German company's main focus is not explicitly stated in the provided metadata. However, the company offers services and has an advisory board. Jörg Spiekerkötter has been the CEO of the company since 2011. | Chief Executive Officer | 01/01/2011 |
Dr. Loges + Co. GmbH
 Dr. Loges + Co. GmbH Pharmaceuticals: MajorHealth Technology Dr. Loges + Co. GmbH is a German company that specializes in producing lipowheat extract, osteoporosis medication, phytopharmaceuticals, homeopathic remedies, and vital supplements. The private company is based in Winsen, Germany, and the CEOs are Gregor Loges and Carsten Timmering. The company also offers well-aging products that provide natural support for the body and mind. The company provides information and downloads about their products and active ingredients, as well as a pharmacy locator and reimbursement eligibility check in their service section. | Director/Board Member | - |
Anciens postes connus de Jörg Spiekerkötter
| Sociétés | Poste | Fin |
|---|---|---|
| CONERGY AG | Director of Finance/CFO | 31/10/2010 |
Organon BioSciences NV
 Organon BioSciences NV Pharmaceuticals: MajorHealth Technology Organon Biosciences NV specializes in biopharmaceutical manufacturing and distribution services. It develops products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care, and neuroscience, immunology, animal health, and oncology. The company’s products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, cold/flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. It was founded in 1923 and is headquartered in Oss, the Netherlands. | Director of Finance/CFO | 01/05/2007 |
| Bayer Schering Pharma AG | Director of Finance/CFO | 01/09/2006 |
| Hoechst Schering AgrEvo GmbH | General Counsel | 01/01/1999 |
| PAION AG | Chairman | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PAION AG | Health Technology |
| Entreprise privées | 6 |
|---|---|
| Bayer Schering Pharma AG | Health Technology |
Conergy AG
 Conergy AG SemiconductorsElectronic Technology Conergy AG specializes in the manufacture of solar products. It also engages in the installation of photovoltaic systems and solar thermal plants. The company was founded by Hans-Martin Rüter, Elisabeth Ammer, Dieter Ammer, Nikolaus Krane, Angiolo Laviziano, Hans Bucher, Andreas Rittstieg, Renate Rüter, Andreas Rüter, Christina Rüter, Franziska Rüter, Annabelle Theurer, Dieter Krane, and Ennio Laviziano on December 22, 1998 and is headquartered in Berlin, Germany. | Electronic Technology |
Organon BioSciences NV
Organon BioSciences NV Pharmaceuticals: MajorHealth Technology Organon Biosciences NV specializes in biopharmaceutical manufacturing and distribution services. It develops products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care, and neuroscience, immunology, animal health, and oncology. The company’s products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, cold/flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. It was founded in 1923 and is headquartered in Oss, the Netherlands. | Health Technology |
| Hoechst Schering AgrEvo GmbH | |
JSP-Invest GmbH
JSP-Invest GmbH Financial ConglomeratesFinance JSP-Invest GmbH is a private company based in Potsdam, Germany. The German company's main focus is not explicitly stated in the provided metadata. However, the company offers services and has an advisory board. Jörg Spiekerkötter has been the CEO of the company since 2011. | Finance |
Dr. Loges + Co. GmbH
Dr. Loges + Co. GmbH Pharmaceuticals: MajorHealth Technology Dr. Loges + Co. GmbH is a German company that specializes in producing lipowheat extract, osteoporosis medication, phytopharmaceuticals, homeopathic remedies, and vital supplements. The private company is based in Winsen, Germany, and the CEOs are Gregor Loges and Carsten Timmering. The company also offers well-aging products that provide natural support for the body and mind. The company provides information and downloads about their products and active ingredients, as well as a pharmacy locator and reimbursement eligibility check in their service section. | Health Technology |
